tiprankstipranks
Advertisement
Advertisement

NBIX Stock Latest News

Neurocrine Biosciences Earnings Call Signals Scaled Growth
Company AnnouncementsNeurocrine Biosciences Earnings Call Signals Scaled Growth
2m ago
NBIX
Neurocrine price target raised to $249 from $246 at Citi
PremiumThe Fly
Neurocrine price target raised to $249 from $246 at Citi
1d ago
NBIX
Neurocrine Biosciences: Strong Q2 Execution, Expanded Pipeline, and Multi-Billion-Dollar Peak Sales Potential Support Buy Rating
PremiumRatings
Neurocrine Biosciences: Strong Q2 Execution, Expanded Pipeline, and Multi-Billion-Dollar Peak Sales Potential Support Buy Rating
1d ago
NBIX
Wells Fargo recommends buying Neurocrine on weakness after solid quarter
PremiumThe Fly
Wells Fargo recommends buying Neurocrine on weakness after solid quarter
1d ago
NBIX
Neurocrine price target raised to $196 from $193 at Morgan Stanley
PremiumThe Fly
Neurocrine price target raised to $196 from $193 at Morgan Stanley
1d ago
NBIX
Neurocrine price target raised to $220 from $200 at TD Cowen
PremiumThe FlyNeurocrine price target raised to $220 from $200 at TD Cowen
1d ago
NBIX
Neurocrine price target raised to $190 from $170 at Deutsche Bank
Premium
The Fly
Neurocrine price target raised to $190 from $170 at Deutsche Bank
1d ago
NBIX
Neurocrine price target raised to $214 from $199 at BofA
Premium
The Fly
Neurocrine price target raised to $214 from $199 at BofA
1d ago
NBIX
Neurocrine price target raised to $215 from $210 at Cantor Fitzgerald
PremiumThe Fly
Neurocrine price target raised to $215 from $210 at Cantor Fitzgerald
1d ago
NBIX
Neurocrine price target raised to $204 from $200 at Needham
PremiumThe Fly
Neurocrine price target raised to $204 from $200 at Needham
2d ago
NBIX
Neurocrine price target raised to $210 from $207 at Piper Sandler
PremiumThe Fly
Neurocrine price target raised to $210 from $207 at Piper Sandler
2d ago
NBIX
Neurocrine price target raised to $225 from $186 at Baird
PremiumThe Fly
Neurocrine price target raised to $225 from $186 at Baird
2d ago
NBIX
Neurocrine price target raised to $215 from $188 at Stifel
PremiumThe FlyNeurocrine price target raised to $215 from $188 at Stifel
2d ago
NBIX
Neurocrine price target raised to $222 from $200 at Guggenheim
Premium
The Fly
Neurocrine price target raised to $222 from $200 at Guggenheim
2d ago
NBIX
Neurocrine Biosciences: Strong Q2 Beat, Upgraded Outlook, and Price Target Raised to $204 Support Buy Rating
Premium
Ratings
Neurocrine Biosciences: Strong Q2 Beat, Upgraded Outlook, and Price Target Raised to $204 Support Buy Rating
2d ago
NBIX
Phil Nadeau Raises Neurocrine Price Target to $220 on Exceptional Q2 Beat and Strength Across Ingrezza and Crenessity
PremiumRatings
Phil Nadeau Raises Neurocrine Price Target to $220 on Exceptional Q2 Beat and Strength Across Ingrezza and Crenessity
2d ago
NBIX
Neurocrine reports Q2 adjusted EPS $2.85, consensus $1.98
PremiumThe Fly
Neurocrine reports Q2 adjusted EPS $2.85, consensus $1.98
2d ago
NBIX
Neurocrine raises FY26 Ingrezza net sales view to $2.825B-$2.875B
PremiumThe Fly
Neurocrine raises FY26 Ingrezza net sales view to $2.825B-$2.875B
2d ago
NBIX
Is NBIX a Buy, Before Earnings?
PremiumPre-Earnings
Is NBIX a Buy, Before Earnings?
5d ago
NBIX
Neurocrine appoints Samir Siddhanti as Chief Business Officer
PremiumThe FlyNeurocrine appoints Samir Siddhanti as Chief Business Officer
11d ago
NBIX
Neurocrine price target raised to $200 from $175 at Guggenheim
Premium
The Fly
Neurocrine price target raised to $200 from $175 at Guggenheim
11d ago
NBIX
Neurocrine price target raised to $200 from $175 at Wells Fargo
Premium
The Fly
Neurocrine price target raised to $200 from $175 at Wells Fargo
16d ago
NBIX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >